Compare Kulicke & Soffa Industries, Inc. with Similar Stocks
Stock DNA
Industrial Manufacturing
USD 5,011 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.58
-2.18%
6.07
Revenue and Profits:
Net Sales:
200 Million
(Quarterly Results - Dec 2025)
Net Profit:
17 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
40.88%
0%
40.88%
6 Months
53.47%
0%
53.47%
1 Year
82.61%
0%
82.61%
2 Years
32.0%
0%
32.0%
3 Years
24.64%
0%
24.64%
4 Years
10.72%
0%
10.72%
5 Years
39.77%
0%
39.77%
Kulicke & Soffa Industries, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-1.64%
EBIT Growth (5y)
-176.31%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.67
Sales to Capital Employed (avg)
0.74
Tax Ratio
46.63%
Dividend Payout Ratio
20,500.00%
Pledged Shares
0
Institutional Holding
99.86%
ROCE (avg)
44.78%
ROE (avg)
17.35%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
6.07
EV to EBIT
-178.09
EV to EBITDA
-530.51
EV to Capital Employed
12.97
EV to Sales
6.60
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-7.28%
ROE (Latest)
-2.18%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bullish
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 73 Schemes (42.1%)
Foreign Institutions
Held by 123 Foreign Institutions (11.46%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
199.60
177.60
12.39%
Operating Profit (PBDIT) excl Other Income
23.30
1.50
1,453.33%
Interest
0.00
0.00
Exceptional Items
-1.80
2.80
-164.29%
Consolidate Net Profit
16.80
6.40
162.50%
Operating Profit Margin (Excl OI)
97.10%
-14.10%
11.12%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 12.39% vs 19.68% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is 162.50% vs 293.94% in Sep 2025
Annual Results Snapshot (Consolidated) - Sep'25
Sep'25
Sep'24
Change(%)
Net Sales
654.10
706.20
-7.38%
Operating Profit (PBDIT) excl Other Income
-16.50
-19.90
17.09%
Interest
0.10
0.10
Exceptional Items
-45.20
-47.40
4.64%
Consolidate Net Profit
0.20
-69.00
100.29%
Operating Profit Margin (Excl OI)
-52.70%
-63.30%
1.06%
USD in Million.
Net Sales
YoY Growth in year ended Sep 2025 is -7.38% vs -4.89% in Sep 2024
Consolidated Net Profit
YoY Growth in year ended Sep 2025 is 100.29% vs -220.84% in Sep 2024
About Kulicke & Soffa Industries, Inc. 
Kulicke & Soffa Industries, Inc.
Industrial Manufacturing
Kulicke and Soffa Industries, Inc. designs, manufactures and sells capital equipment and expendable tools used to assemble semiconductor devices, including integrated circuits (ICs), high and low powered discrete devices, light-emitting diodes (LEDs) and power modules. The Company also services, maintains, repairs and upgrades equipment, all used to assemble semiconductor devices. The Company supplies a range of bonding equipment. It operates through two segments: Capital Equipment and Aftermarket Products and Services (APS). The Capital Equipment segment manufactures and sells a line of ball bonders, wedge bonders, advanced packaging and surface mount technology solutions. The APS segment manufactures and sells expendable tools for a range of semiconductor packaging applications. Its customers primarily consist of semiconductor device manufacturers, outsourced semiconductor assembly and test providers (OSATs), other electronics manufacturers and automotive electronics suppliers.
Company Coordinates 
Company Details
23A Serangoon North Avenue 5, #01-01 K&S Corporate Headquarters None : 554369
Registrar Details






